What does CUSIP G63637139 represent in this 13F holders report?

CUSIP G63637139 is the security identifier for NBRVF - NABRIVA THERAPEUTICS PLC - SHS NEW 2022 used to aggregate holder disclosures.

How many institutions held NBRVF - NABRIVA THERAPEUTICS PLC - SHS NEW 2022 in Q3 2023?

No institutional holders were reported for NBRVF - NABRIVA THERAPEUTICS PLC - SHS NEW 2022 in Q3 2023; review adjacent reporting periods for trend context.

NABRIVA THERAPEUTICS PLC - SHS NEW 2022 (NBRVF)

CUSIP: G63637139

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class: Equity / SHS NEW 2022
Total 13F shares: 0
Share change: -57,627
Total reported value: $0
Number of holders: 0
Value change: -$97,317
Number of sells: 8

Quarterly Holders Quick Answers

What is CUSIP G63637139?
CUSIP G63637139 identifies NBRVF - NABRIVA THERAPEUTICS PLC - SHS NEW 2022 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q2 2023

Recent filing periods for CUSIP G63637139:

Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022

NABRIVA THERAPEUTICS PLC - SHS NEW 2022 (NBRVF)

Q3 2023 13F Holders as of 30 Sep 2023

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of NBRVF - NABRIVA THERAPEUTICS PLC - SHS NEW 2022 as of Q3 2023.